Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells
Chen Zheng, Mei Zhou, Jie Sun, et al.
Chemico-Biological Interactions (2019) Vol. 310, pp. 108688-108688
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
Leela Paladugu, Abeer Gharaibeh, Nivya Kolli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 860-860
Open Access | Times Cited: 57
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 53
Advances in polysaccharides of natural source of the anti-Alzheimer's disease effect and mechanism
Zhiyuan Zhang, Shuai Wang, Haining Tan, et al.
Carbohydrate Polymers (2022) Vol. 296, pp. 119961-119961
Closed Access | Times Cited: 46
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
Puja Ghosh, Rosaria Anna Fontanella, Lucia Scisciola, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4872-4884
Open Access | Times Cited: 26
Green Synthesis of Cerium Oxide Nanoparticles, Characterization, and Their Neuroprotective Effect on Hydrogen Peroxide-Induced Oxidative Injury in Human Neuroblastoma (SH-SY5Y) Cell Line
M. Mamatha, Mohammad Azam Ansari, M. Yasmin Begum, et al.
ACS Omega (2024) Vol. 9, Iss. 2, pp. 2639-2649
Open Access | Times Cited: 17
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Neuroprotective effects of tranexamic acid against hydrogen peroxide-induced cytotoxicity on human neuroblastoma SH-SY5Y cells
Ali Niapour, Yavar Mohebi, Hossein Ghalehnoei
Neurological Research (2025), pp. 1-9
Closed Access | Times Cited: 1
Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in Aβ1–42 induced C57BL/6 mice for Alzheimer's disease treatment
A Prabakaran, Debarati Rakshit, Inklisan Patel, et al.
International Journal of Biological Macromolecules (2025), pp. 141136-141136
Closed Access | Times Cited: 1
Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases
Shang‐Der Chen, Yao‐Chung Chuang, Tsu‐Kung Lin, et al.
European Journal of Pharmacology (2022) Vol. 938, pp. 175439-175439
Closed Access | Times Cited: 35
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Semaglutide-mediated protection against Aβ correlated with enhancement of autophagy and inhibition of apotosis
Yan-fang Chang, Di Zhang, Weimin Hu, et al.
Journal of Clinical Neuroscience (2020) Vol. 81, pp. 234-239
Closed Access | Times Cited: 49
Carnosine ameliorates age-related dementia via improving mitochondrial dysfunction in SAMP8 mice
Zhao Dai, Xinyi Lu, Wenli Zhu, et al.
Food & Function (2020) Vol. 11, Iss. 3, pp. 2489-2497
Closed Access | Times Cited: 22
Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease
Qinghong Liao, Qi Li, Yifan Zhao, et al.
Bioorganic Chemistry (2020) Vol. 99, pp. 103844-103844
Closed Access | Times Cited: 21
Citrulline prevents age-related LTP decline in old rats
Antonin Ginguay, Anne Regazzetti, Olivier Laprévôte, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Identification of a novel oligopeptide from defatted walnut meal hydrolysate as a potential neuroprotective agent
Feng Gao, Zixuan Zhang, Nannan Xue, et al.
Food & Function (2024) Vol. 15, Iss. 10, pp. 5566-5578
Closed Access | Times Cited: 2
Liraglutide ameliorates diabetes-associated cognitive dysfunction via rescuing autophagic flux
Meng Zhang, Wenhui Yan, Ye Yu, et al.
Journal of Pharmacological Sciences (2021) Vol. 147, Iss. 3, pp. 234-244
Open Access | Times Cited: 14
RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus
John T. O’Brien, Leonidas Chouliaras, Janet Sultana, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 10
GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer’s disease
Gourav Chandan, Upasana Ganguly, Soumya Pal, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 482-489
Closed Access | Times Cited: 5
Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways
Xiaomei Yang, Yun Li, Lin Chen, et al.
Pharmaceutical Biology (2020) Vol. 58, Iss. 1, pp. 686-694
Open Access | Times Cited: 14
Protective effect of Hydroxysafflor Yellow A on cerebral ischemia reperfusion-injury by regulating GSK3β-mediated pathways
Xiaomei Yang, Lin Chen, Yun Li, et al.
Neuroscience Letters (2020) Vol. 736, pp. 135258-135258
Closed Access | Times Cited: 13
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Xiao‐Yu Liu, Ni Zhang, Sheng‐Xiao Zhang, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 10, pp. 7749-7769
Closed Access | Times Cited: 11
Pharmacological implications of ipriflavone against environmental metal–induced neurodegeneration and dementia in rats
Hend M. Hussien, Doaa A. Ghareeb, Hany E. A. Ahmed, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 46, pp. 65349-65362
Closed Access | Times Cited: 10
Novel insights into the augmented effect of curcumin and liraglutide in ameliorating cisplatin-induced nephrotoxicity in rats: Effects on oxidative stress, inflammation, apoptosis and pyroptosis via GSK-3β
Rehab M. El‐Gohary, Asmaa A. Ghalwash, Marwa Mahmoud Awad, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 749, pp. 109801-109801
Closed Access | Times Cited: 4
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease
Xianghao Zeng, Shaobing Cheng, Huilan Li, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 1
Exploring Allocryptopine as a Neuroprotective Agent Against Oxidative Stress-Induced Neural Apoptosis via Akt/GSK-3β/Tau Pathway Modulation
Belma Aslım, Serap Nigdelioglu Dolanbay, Sahra Setenay Baran
Computational Biology and Chemistry (2024) Vol. 112, pp. 108144-108144
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top